At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19
Condition(s):Covid19Last Updated:March 18, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Covid19Last Updated:March 18, 2022Terminated
Condition(s):COVID-19Last Updated:November 16, 2021Completed
Condition(s):Covid19Last Updated:August 26, 2021Unknown status
Condition(s):COVID-19Last Updated:October 2, 2023No longer available
Condition(s):Covid19Last Updated:March 29, 2022Unknown status
Condition(s):COVID-19Last Updated:July 26, 2022Terminated
Condition(s):Covid19; Nosocomial Infection; SARS-CoV2 InfectionLast Updated:April 19, 2023Terminated
Condition(s):COVID-19; SARS-CoV2Last Updated:February 4, 2022Completed
Condition(s):HealthyLast Updated:December 6, 2021Completed
Condition(s):COVID-19Last Updated:November 12, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.